A Review of Energy-Based Device Interventions to Treat Keloid Scars

November 2024 | Volume 23 | Issue 11 | 998 | Copyright © November 2024


Published online October 17, 2024

doi:10.36849/JDD.8210R1

Hira Ghani DOa, Alicia Podwojniak BSb, Sasha Ghofrani BSc, Isabella Tan BSd, Rebecca Fliorent BSb, Khalil Khatri MDe

aNorthwestern University Feinberg School of Medicine, Chicago, IL
bRowan-Virtua School of Osteopathic Medicine, Stratford, NJ
cPhiladelphia College of Osteopathic Medicine, Philadelphia, PA
dRutgers- Robert Wood Johnson Medical School, New Brunswick, NJ
eSkin and Laser Surgery Center of New England, Nashua, NH

Abstract
Keloids are thickened raised scars that develop due to injury and grow beyond the boundaries of their original wound, mostly affecting individuals with skin of color. This review explores the use of energy-based devices to treat keloids, both using laser monotherapy and in combination with other drugs. Laser therapy alone has shown efficacy in treating keloids. Combination laser therapy has better keloid reduction when administered with steroids, 5-fluorouracil (5-FU), and verapamil. However, monotherapy has had less adverse reactions including dermal atrophy and local pain. Therefore, physician discretion is essential when considering treatment. This review highlights the efficacy of energy-based devices (EBDs), alone and in combination. It also reveals the need to have tailored approaches with patients. Further research is needed to develop more comprehensive treatment standards for keloids using EBDs alone or
in combination.

J Drugs Dermatol. 2024;23(11):998-1002. doi:10.36849/JDD.8210R1

INTRODUCTION

Keloids are benign dermal fibroproliferative tumors, manifesting as thickened, raised scars that arise due to injury.1 Keloids grow beyond the wound boundaries and appear firm, smooth, shiny, and may be dyschromic. They can cause psychosocial, physical, and cosmetic distress. Keloids often arise in patients with skin of color and can be caused by trauma to the skin, including physical injury, surgery, piercings, burns, and acne lesions.2-5 The pathophysiology of keloid formation is complex and poorly understood. Researchers believe that keloids form due to overproduction of collagen and fibroblasts with increased levels of transforming growth factor and platelet-derived growth factor.6

Common treatment therapies include intralesional corticosteroid injections, silicone gel sheets, pressure therapy, cryotherapy, and surgical excision.7,8 There is no universal treatment protocol for keloids due to their heterogeneity. Keloids remain a challenging dermatologic condition to treat due to their high recurrence rate, complex pathogenesis, size and location, and limited standardization. Energy-based device therapies (EBDs) such as laser therapy, radiofrequency therapy, and intense pulsed light (IPL) have emerged as potential non-invasive, and effective methods of reducing the appearance of keloids.9 These EBDs target blood vessels within the keloid tissue to decrease inflammation, help remodel collagen to flatten and soften the keloid, and reduce pigmentation by breaking down the melanin within the scar tissue. Laser therapy can also be used in combination with other treatments, such as corticosteroid injections, to further decrease keloid appearance and prevent reoccurrence.10

This review explores different EBD therapies, such as lasers in combination with other modalities and laser monotherapy, as well as the efficacy of radiofrequency and intense pulsed light in treating keloids.

MATERIALS AND METHODS

A literature review was performed using SCOPUS and PubMed databases to explore contemporary applications of lasers in keloid treatment. The search covered studies published between January 2011 and September 2023. The primary search terms "keloid," "lasers," "combination therapy," "Nd:YAG," "fractional CO2," "pulsed dye," "radiofrequency," and "intense pulse light" were used as isolated and combined search terms. Inclusion criteria encompassed English-language articles of various study types, such as randomized controlled trials, systematic reviews, clinical trials, retrospective single-center studies, case series, and case reports. Exclusion criteria included non-English studies. The review aimed to analyze efficacy compared to